# Curcumin (1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/curcumin-1-6-heptadiene-3-5-dione
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-31
**Evidence Score:** 4 / 10
**Category:** Compound
**Also Known As:** Diferuloylmethane, Turmeric extract, C.I. 75300, Natural Yellow 3, E100, Curcuma longa extract, Indian saffron extract, Haldi extract, Ukon extract, Circumin, Curcumine, Kacha haldi, Haridra

## Overview

Curcumin is the primary polyphenolic curcuminoid in turmeric (Curcuma longa), constituting roughly 77% of its curcuminoid content. It exerts anti-inflammatory and [antioxidant](/ingredients/condition/antioxidant) effects primarily by inhibiting NF-κB signaling and suppressing [pro-inflammatory cytokine](/ingredients/condition/inflammation) production.

## Health Benefits

• Reduces inflammation markers: Meta-analysis of 5,870 participants showed significant reductions in CRP (ES=-0.74), IL-6 (ES=-1.07), and TNF-α (ES=-1.92) with moderate certainty evidence
• Improves rheumatoid arthritis symptoms: Meta-analysis of 6 RCTs (n=244) demonstrated significant improvement in ACR20 response (SMD=4.35, p<0.0001), though evidence certainty was very low
• Reduces COVID-19 mortality: Meta-analysis of 13 RCTs found reduced all-cause mortality (RR 0.38) and non-recovery (RR 0.54) with moderate certainty evidence
• Supports autoimmune conditions: 2022 meta-analysis found improvements in clinical outcomes for RA, ulcerative colitis, and oral lichen planus, though limited by small sample sizes
• Modulates [inflammatory pathway](/ingredients/condition/inflammation)s: Inhibits NF-κB signaling and COX-2 enzymes, with stronger effects in trials with >300 participants or mean age >45 years

## Mechanism of Action

Curcumin inhibits the NF-κB transcription factor by blocking IκB kinase (IKK) phosphorylation, thereby preventing downstream transcription of [pro-inflammatory cytokine](/ingredients/condition/inflammation)s including TNF-α, IL-1β, and IL-6. It also directly scavenges [reactive oxygen species](/ingredients/condition/antioxidant) (ROS) and upregulates Nrf2-mediated antioxidant response elements, inducing HO-1 and superoxide dismutase expression. Additionally, curcumin inhibits COX-2 and 5-LOX enzymes, reducing prostaglandin E2 and leukotriene B4 synthesis.

## Clinical Summary

A meta-analysis of 5,870 participants demonstrated significant reductions in C-reactive protein (effect size −0.74), IL-6 (ES −1.07), and TNF-α (ES −1.92) with moderate-certainty evidence. A separate meta-analysis of 6 RCTs (n=244) found significant improvement in rheumatoid arthritis symptom scores compared to placebo or NSAIDs. Bioavailability is a recognized limitation, as standard curcumin has poor intestinal absorption; phospholipid complexes (Meriva), nanoparticle formulations, and piperine co-administration (20 mg enhancing absorption by ~2,000%) meaningfully improve plasma concentrations. Evidence quality across trials is moderate, with heterogeneity in formulations, doses, and outcome measures warranting cautious interpretation.

## Nutritional Profile

Curcumin is a pure polyphenolic bioactive compound, not a whole food, and therefore contains no meaningful macronutrients (carbohydrates, fats, or proteins) in its isolated form. As a concentrated extract, it is essentially 100% active compound by dry weight when purified. Key bioactive identity: 1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione, molecular weight 368.38 g/mol, CAS 458-37-7. It is the principal curcuminoid in turmeric (Curcuma longa), typically comprising 77% of the curcuminoid fraction alongside demethoxycurcumin (~17%) and bisdemethoxycurcumin (~3%). In raw turmeric root, curcumin constitutes approximately 2–5% dry weight (roughly 200–500 mg per 10g fresh turmeric). In commercial standardized turmeric extracts, curcuminoid concentration is typically 95% by weight. Bioavailability: Curcumin in its native form is notoriously poorly bioabsorbed — oral bioavailability is <1% due to low aqueous solubility, rapid intestinal [metabolism](/ingredients/condition/weight-management), and rapid systemic elimination. Peak plasma concentration after 2g oral dose is approximately 0.006 µg/mL. Bioavailability is substantially enhanced by: piperine co-administration (20 mg piperine increases absorption by ~2,000%), phospholipid complexes (Meriva®, ~29-fold increase), nanoparticle/liposomal formulations, and lipid-based delivery systems. Primary metabolites include tetrahydrocurcumin, curcumin glucuronide, and curcumin sulfate. No significant vitamin, mineral, or fiber content is present in isolated curcumin form.

## Dosage & Preparation

Clinically studied doses range from 300-1900 mg/day of curcumin in standardized extracts (typically 95% curcuminoids), administered for 4.5-10.5 weeks. Studies emphasized bioavailable forms over raw turmeric powder, often with piperine or special formulations to enhance absorption. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Curcumin is generally well-tolerated at doses up to 8 g/day in short-term trials, with gastrointestinal discomfort (nausea, diarrhea, bloating) being the most common adverse effect at higher doses. It inhibits CYP3A4, CYP1A2, and P-glycoprotein, raising plasma levels of drugs such as warfarin, tacrolimus, and certain chemotherapy agents, necessitating caution with concurrent use. Curcumin has antiplatelet activity and should be used cautiously alongside anticoagulants or antiplatelet drugs, and discontinued at least two weeks before surgery. Safety data in pregnancy are insufficient; high-dose supplemental curcumin is not recommended during pregnancy as animal data suggest potential uterotonic effects.

## Scientific Research

A 2024 comprehensive meta-analysis included 103 RCTs (n=7,216) across 42 outcomes, confirming benefits in inflammation (PMID: 39478418). Multiple meta-analyses support curcumin's [anti-inflammatory](/ingredients/condition/inflammation) effects, including reduced CRP, IL-6, and TNF-α (PMC9870680, PMID: 30402990), improvements in rheumatoid arthritis (PMID: 41601662), and reduced COVID-19 mortality (PMID: 36640146).

## Historical & Cultural Context

Curcumin from Curcuma longa has been used for millennia in Ayurvedic medicine (India, >4,000 years) for [inflammation](/ingredients/condition/inflammation), arthritis, digestive disorders, and wound healing, often as a spice or paste. Raw turmeric rhizomes contain 3-5% curcumin naturally.

## Synergistic Combinations

Piperine, Omega-3 fatty acids, Boswellia serrata, Ginger, Quercetin

## Frequently Asked Questions

### What is the effective daily dose of curcumin for inflammation?

Most clinical trials showing anti-inflammatory benefit used doses of 500–1,500 mg of curcumin per day, divided across 2–3 servings. Because standard curcumin has poor bioavailability (~1% absorption), formulations with piperine (BioPerine), phospholipid complexes (Meriva), or nanoparticles (Theracurmin) are typically needed to achieve therapeutic plasma concentrations at these doses.

### Does curcumin interact with blood thinners like warfarin?

Yes, curcumin inhibits platelet aggregation and CYP2C9-mediated warfarin metabolism, which can significantly elevate warfarin plasma levels and increase bleeding risk. Patients taking warfarin or other anticoagulants should consult their physician before supplementing, and INR monitoring is advisable if curcumin is added to the regimen.

### How does piperine increase curcumin absorption?

Piperine, the active alkaloid in black pepper, inhibits intestinal glucuronidation enzymes and P-glycoprotein efflux transporters that rapidly metabolize and expel curcumin. Co-administration of 20 mg piperine with 2 g curcumin has been shown to increase curcumin bioavailability by approximately 2,000% in human pharmacokinetic studies, significantly raising peak plasma concentrations.

### Can curcumin help with rheumatoid arthritis pain?

A meta-analysis of 6 RCTs involving 244 participants found that curcumin supplementation produced statistically significant improvements in joint pain and swelling scores in rheumatoid arthritis patients, with some trials showing efficacy comparable to diclofenac sodium at 50 mg twice daily. Effects are attributed to NF-κB and COX-2 inhibition, reducing synovial prostaglandin E2 and inflammatory cytokine levels.

### Is curcumin safe to take long-term?

Phase I clinical trials have reported curcumin to be safe at doses up to 8 g/day for 3 months, with no serious adverse events observed. Long-term safety data beyond 6 months are limited, but observational evidence from populations with high dietary turmeric intake suggests a favorable safety profile; the primary concerns with prolonged high-dose use are GI irritation and potential drug interactions via CYP enzyme inhibition.

### What is the difference between curcumin and turmeric powder?

Curcumin is the specific bioactive compound isolated from turmeric root, comprising only 2-8% of turmeric powder by weight. While turmeric powder contains curcumin plus other compounds like volatile oils and polysaccharides, standardized curcumin supplements provide consistent, concentrated doses that are typically 10-95% pure curcumin. This makes curcumin extracts significantly more potent for achieving the anti-inflammatory benefits demonstrated in clinical research than whole turmeric powder alone.

### Who should avoid curcumin supplementation?

People with active bleeding disorders, those scheduled for surgery, individuals with bile duct obstruction, and those taking anticoagulant medications should consult a healthcare provider before curcumin use due to potential blood-thinning effects and gallbladder stimulation. Pregnant women should also seek medical guidance, as high-dose curcumin may affect pregnancy, though culinary amounts in food are generally considered safe. Individuals with curcumin sensitivity or turmeric allergy should avoid this ingredient entirely.

### How strong is the clinical evidence supporting curcumin's anti-inflammatory effects?

Meta-analyses involving over 5,800 participants demonstrate moderate-to-high certainty evidence that curcumin significantly reduces key inflammation markers: C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α), with effect sizes ranging from -0.74 to -1.92. However, evidence for specific conditions like rheumatoid arthritis improvement is rated very low certainty despite statistically significant findings, indicating larger and better-designed trials are needed. This suggests curcumin's general anti-inflammatory activity is well-supported, but condition-specific benefits require further research validation.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*